Sign up to save your podcasts
Or
Share Variation in Endpoints for FDA Approved Migraine Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Variation in Endpoints for FDA Approved Migraine Therapies
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.
Read the related article in Neurology.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.
Read the related article in Neurology.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
315 Listeners
Practical Neurology Podcast
47 Listeners
JAMA Clinical Reviews
496 Listeners
The Curbsiders Internal Medicine Podcast
3,316 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,103 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
518 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
365 Listeners
Continuum Audio
78 Listeners